Is my portfolio
One Report to Answer all your Questions!
Natco Pharma Ltd.
BSE: 524816 | NSE: NATCOPHARM
Small Cap | Pharmaceuticals & Drugs
916.25
-10.90 (-1.18%) NATCO Pharma informs about press release
Date: 25-07-2022NATCO Pharma has informed that it enclosed the press release today titled ‘NATCO Announces Approval of its ANDA for Cabazitaxel Intravenous Solution (generic for Jevtana Kit®)’ under Regulation 30 of SEBI (LODR) Regulations 2015 for the information.
The above information is a part of company’s filings submitted to BSE.